193 related articles for article (PubMed ID: 8477209)
1. Amphotericin B in resistant kala-azar in Bihar.
Thakur CP; Sinha GP; Pandey AK; Barat D; Sinha PK
Natl Med J India; 1993; 6(2):57-60. PubMed ID: 8477209
[TBL] [Abstract][Full Text] [Related]
2. Daily versus alternate-day regimen of amphotericin B in the treatment of kala-azar: a randomized comparison.
Thakur CP; Sinha GP; Pandey AK; Barat D; Singh RK
Bull World Health Organ; 1994; 72(6):931-6. PubMed ID: 7867139
[TBL] [Abstract][Full Text] [Related]
3. Experience with amphotericin B in sodium stibogluconate--unresponsive cases of visceral Leishmaniasis in north Bihar.
Giri OP; Singh AN
J Assoc Physicians India; 1994 Sep; 42(9):690-1. PubMed ID: 7883660
[TBL] [Abstract][Full Text] [Related]
4. Observations on amphotericin B treatment of kala-azar given in a rural set up in Bihar, India.
Thakur CP; Ahmed S
Indian J Med Res; 2001 Jan; 113():14-8. PubMed ID: 11280166
[TBL] [Abstract][Full Text] [Related]
5. Comparison of treatment regimens of kala-azar based on culture & sensitivity of amastigotes to sodium antimony gluconate.
Thakur CP; Thakur S; Narayan S; Sinha A
Indian J Med Res; 2008 Jun; 127(6):582-8. PubMed ID: 18765878
[TBL] [Abstract][Full Text] [Related]
6. Amphotericin B therapy in kala-azar.
Giri OP
J Indian Med Assoc; 1993 Apr; 91(4):91-3. PubMed ID: 8409490
[TBL] [Abstract][Full Text] [Related]
7. The treatment of kala-azar during pregnancy.
Thakur CP; Sinha GP; Sharma V; Barat D
Natl Med J India; 1993; 6(6):263-5. PubMed ID: 7950931
[TBL] [Abstract][Full Text] [Related]
8. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
Das VN; Ranjan A; Bimal S; Siddique NA; Pandey K; Kumar N; Verma N; Singh VP; Sinha PK; Bhattacharya SK
Natl Med J India; 2005; 18(3):131-3. PubMed ID: 16130613
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.
Berman JD; Badaro R; Thakur CP; Wasunna KM; Behbehani K; Davidson R; Kuzoe F; Pang L; Weerasuriya K; Bryceson AD
Bull World Health Organ; 1998; 76(1):25-32. PubMed ID: 9615494
[TBL] [Abstract][Full Text] [Related]
10. A new strategy for elimination of kala-azar from rural Bihar.
Thakur CP
Indian J Med Res; 2007 Nov; 126(5):447-51. PubMed ID: 18160749
[TBL] [Abstract][Full Text] [Related]
11. Injectable paromomycin for Visceral leishmaniasis in India.
Sundar S; Jha TK; Thakur CP; Sinha PK; Bhattacharya SK
N Engl J Med; 2007 Jun; 356(25):2571-81. PubMed ID: 17582067
[TBL] [Abstract][Full Text] [Related]
12. Single-dose liposomal amphotericin B for visceral leishmaniasis in India.
Sundar S; Chakravarty J; Agarwal D; Rai M; Murray HW
N Engl J Med; 2010 Feb; 362(6):504-12. PubMed ID: 20147716
[TBL] [Abstract][Full Text] [Related]
13. Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar.
Maheshwari A; Seth A; Kaur S; Aneja S; Rath B; Basu S; Patel R; Dutta AK
Pediatr Infect Dis J; 2011 Feb; 30(2):180-1. PubMed ID: 20823781
[TBL] [Abstract][Full Text] [Related]
14. A randomized comparison of classical mode of administration of amphotericin B with its newer modes of administration in kala-azar.
Thakur CP; Kumar P; Kumar N; Singh GN; Singh AK; Narain S
J Assoc Physicians India; 1998 Sep; 46(9):779-83. PubMed ID: 11229246
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of amphotericin B as a first line drug in comparison to sodium stibogluconate in the treatment of fresh cases of kala-azar.
Thakur CP; Sinha GP; Sharma V; Pandey AK; Kumar M; Verma BB
Indian J Med Res; 1993 Jul; 97():170-5. PubMed ID: 8406644
[TBL] [Abstract][Full Text] [Related]
16. Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India.
Thakur CP; Kumar A; Mitra G; Thakur S; Sinha PK; Das P; Bhattacharya SK; Sinha A
Indian J Med Res; 2008 Jul; 128(1):38-44. PubMed ID: 18820357
[TBL] [Abstract][Full Text] [Related]
17. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
[TBL] [Abstract][Full Text] [Related]
18. Correction of serum electrolyte imbalance prevents cardiac arrhythmia during amphotericin B administration.
Thakur CP
Natl Med J India; 1995; 8(1):13-4. PubMed ID: 7696938
[TBL] [Abstract][Full Text] [Related]
19. Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions.
Sundar S; Chakravarty J; Rai VK; Agrawal N; Singh SP; Chauhan V; Murray HW
Clin Infect Dis; 2007 Sep; 45(5):556-61. PubMed ID: 17682988
[TBL] [Abstract][Full Text] [Related]
20. A kala-azar control programme for remote tribal communities.
Thakur CP; Frances Sister ; Therese Sister ; Victoria Sister ; Puspa Sister
World Health Forum; 1994; 15(3):245-7. PubMed ID: 7945751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
